Publication:
Anti-CD10 (56C6) expression in soft tissue sarcomas

Simple item page
dc.contributor.authorDENİZ, Kemal
dc.contributor.authorCoban, Ganime
dc.contributor.authorOkten, Turhan
dc.contributor.institutionauthorÇOBAN, GANİME
dc.date.accessioned2020-10-30T00:13:44Z
dc.date.available2020-10-30T00:13:44Z
dc.date.issued2012-01-01T00:00:00Z
dc.description.abstractCD10 is known to be expressed in certain types of leukemia, in lymphomas and also in various types of carcinoma. However, data regarding CD10 expression in soft tissue sarcomas is scarce. Two hundred and two retrospective soft tissue sarcoma specimens were evaluated for CD10 expression immunohistochemically. The clinical records of these patients were reviewed, and clinical data was obtained for all patients. Our results showed that 90 of the 202 cases were found to express CD10. 72% of malignant fibrous histiocytomas, 45% of fibrosarcomas, 34% of rhabdomyosarcomas, 50% of leiomyosarcomas, 22% of liposarcomas, 72% of malignant peripheral nerve sheath tumors, and 0% of the primitive neuroectodermal tumors were positive for CD10. Nearly half of the soft tissue sarcomas were found to express CD10. Stronger CD10 expression was found in high grade sarcomas. (C) 2012 Elsevier GmbH. All rights reserved.
dc.identifier.citationDENİZ K., Coban G., Okten T., -Anti-CD10 (56C6) expression in soft tissue sarcomas-, PATHOLOGY RESEARCH AND PRACTICE, cilt.208, ss.281-285, 2012
dc.identifier.doi10.1016/j.prp.2012.02.002
dc.identifier.scopus84860763793
dc.identifier.urihttp://hdl.handle.net/20.500.12645/27134
dc.identifier.wosWOS:000305659600003
dc.titleAnti-CD10 (56C6) expression in soft tissue sarcomas
dc.typeArticle
dspace.entity.typePublication
local.avesis.ideceeea32-75cf-4179-9e95-94cd360e9c5e
local.publication.isinternational1
relation.isAuthorOfPublication92813154-621b-468c-8399-8510ae43f718
relation.isAuthorOfPublication.latestForDiscovery92813154-621b-468c-8399-8510ae43f718

Files

Collections

Silinecekler